QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 29, 2006, 26(48):12497-12511; doi:10.1523/JNEUROSCI.3719-06.2006

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Yasuhara, T. Articles by Borlongan, C. V. Search for Related Content PubMed PubMed Citation Articles by Yasuhara, T. Articles by Borlongan, C. V. Pubmed/NCBI databases Medline Plus Health Information Parkinson's Disease Patient Rights

 Previous Article  |  Next Article 

Development/Plasticity/Repair
Transplantation of Human Neural Stem Cells Exerts Neuroprotection in a Rat Model of Parkinson's Disease

Takao Yasuhara,¹ Noriyuki Matsukawa,¹ Koichi Hara,¹ Guolong Yu,¹ Lin Xu,¹ Mina Maki,¹ Seung U. Kim,^2,3 and Cesario V. Borlongan^1,4

¹Department of Neurology, Medical College of Georgia, Augusta, Georgia 30912, ²Disease Research Center, Ajou University School of Medicine, Suwon 443-721, Korea, ³Division of Neurology, University of British Columbia Hospital, Vancouver, British Columbia, Canada V5Z 1M9, and ⁴Research and Affiliations Service Line, Augusta Veterans Affairs Medical Center, Augusta, Georgia 30904

Correspondence should be addressed to Dr. Cesario V. Borlongan, Department of Neurology, Medical College of Georgia, 1120, 15th Street, BI-3080, Augusta, GA 30912-3200. Email: cborlongan{at}mail.mcg.edu

Neural stem cells (NSCs) possess high potencies of self-renewal and neuronal differentiation. We explored here whether transplantation of human NSCs cloned by v-myc gene transfer, HB1.F3 cells, is a feasible therapeutic option for Parkinson's disease. In vivo, green fluorescent protein-labeled HB1.F3 cells (200,000 viable cells in 3 µl of PBS) when stereotaxically transplanted (same-day lesion-transplant paradigm) into the 6-hydroxydopamine-lesioned striatum of rats significantly ameliorated parkinsonian behavioral symptoms compared with controls (vehicle, single bolus, or continuous minipump infusion of trophic factor, or killed cell grafts). Such graft-derived functional effects were accompanied by preservation of tyrosine hydroxylase (TH) immunoreactivity along the nigrostriatal pathway. Grafted HB1.F3 cells survived in the lesioned brain with some labeled with neuronal marker mitogen-activated protein 2 and decorated with synaptophysin-positive terminals. Furthermore, endogenous neurogenesis was activated in the subventricular zone of transplanted rats. To further explore the neuroprotective mechanisms underlying HB1.F3 cell transplantation, we performed cell culture studies and found that a modest number of HB1.F3 cells were TH and dopamine and cAMP-regulated phosphoprotein 32 positive, although most cells were nestin positive, suggesting a mixed population of mature and immature cells. Administration of the HB1.F3 supernatant to human derived dopaminergic SH-SY5Y cells and fetal rat ventral mesencephalic dopaminergic neurons protected against 6-hydroxydopamine neurotoxicity by suppressing apoptosis through Bcl-2 upregulation, which was blocked by anti-stem cell factor antibody alone, the phosphatidylinositol 3-kinase/Akt inhibitor LY294002 [2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one] alone, or a combination of both. These results suggest that HB1.F3 cell transplantation exerts neuroprotective effects against dopaminergic depletion in vitro and in vivo because of trophic factor secretion and neuronal differentiation.

Key words: apoptosis; neurogenesis; neuroprotection; neurodegeneration; stem cell factor; trophic

---

Received April 25, 2006; revised Oct. 23, 2006; accepted Oct. 25, 2006.

Correspondence should be addressed to Dr. Cesario V. Borlongan, Department of Neurology, Medical College of Georgia, 1120, 15th Street, BI-3080, Augusta, GA 30912-3200. Email: cborlongan{at}mail.mcg.edu

This article has been cited by other articles:

				N. D. Bull, G. A. Limb, and K. R. Martin Human Muller Stem Cell (MIO-M1) Transplantation in a Rat Model of Glaucoma: Survival, Differentiation, and Integration Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3449 - 3456. [Abstract] [Full Text] [PDF]

				F. E. O'Keeffe, S. A. Scott, P. Tyers, G. W. O'Keeffe, J. W. Dalley, R. Zufferey, and M. A. Caldwell Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease Brain, March 1, 2008; 131(3): 630 - 641. [Abstract] [Full Text] [PDF]

				H. B. Huttner, P. Janich, M. Kohrmann, J. Jaszai, F. Siebzehnrubl, I. Blumcke, M. Suttorp, M. Gahr, D. Kuhnt, C. Nimsky, et al. The Stem Cell Marker Prominin-1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease Stem Cells, March 1, 2008; 26(3): 698 - 705. [Abstract] [Full Text] [PDF]

				L. Madhavan, V. Ourednik, and J. Ourednik Neural Stem/Progenitor Cells Initiate the Formation of Cellular Networks That Provide Neuroprotection by Growth Factor-Modulated Antioxidant Expression Stem Cells, January 1, 2008; 26(1): 254 - 265. [Abstract] [Full Text] [PDF]

				T. R. Yamasaki, M. Blurton-Jones, D. A. Morrissette, M. Kitazawa, S. Oddo, and F. M. LaFerla Neural Stem Cells Improve Memory in an Inducible Mouse Model of Neuronal Loss J. Neurosci., October 31, 2007; 27(44): 11925 - 11933. [Abstract] [Full Text] [PDF]

				A. K. Shetty and B. Hattiangady Concise Review: Prospects of Stem Cell Therapy for Temporal Lobe Epilepsy Stem Cells, October 1, 2007; 25(10): 2396 - 2407. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help